Stocks · Health care · Biological Products, (No Diagnostic Substances)

Apogee Therapeutics, Inc.

APGE Clue Score20
United States Fiscal year ends December CIK 0001974640 Results filed 10 Aug 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Fairmount Funds Management LLC
7 Aug 2026
Director
Exercised, kept indirect
10,370
$43.85
$454.72K
Fairmount Funds Management LLC
7 Aug 2026
Director
Exercised, kept indirect
31,838
$17.00
$541.25K
Michael Thomas Henderson
16 Apr 2026
Chief Executive Officer
Exercised, kept
3,000
$22.86
$68.58K
Michael Thomas Henderson
31 Jan 2025
Chief Executive Officer
Exercised, kept
8,500
$22.86
$194.31K

What was left out

Form 4 filings counted 113
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 9
Sales on a Rule 10b5-1 plan 95
Sales straight out of an exercise 34
Sales at will 2
Transactions with no price 0
Shares from compensation/vesting 4,853,766
History held since 17 Jul 2023